HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches
| Image |  |
|---|---|
| Description | scientific article published on 29 August 2018 |
| Author/s |
author: Nilanjan Adhikari Sk. Abdul Amin |
| Publication date | August 29, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |